Gottesman MM - Search Results

1

Detection of multidrug resistance (MDR1) gene RNA expression in human tumors by a sensitive ribonuclease protection assay.

Ueda K, Yamano Y, Kioka N, Kakehi Y, Yoshida O, Gottesman MM, Pastan I, Komano T. Ueda K, et al. Among authors: gottesman mm. Jpn J Cancer Res. 1989 Nov;80(11):1127-32. doi: 10.1111/j.1349-7006.1989.tb02269.x. Jpn J Cancer Res. 1989. PMID: 2481665 Free PMC article.

2

In situ localization of the human multidrug-resistance gene mRNA using thymine-thymine dimerized single-stranded cDNA.

Sugawara I, Koji T, Ueda K, Pastan I, Gottesman MM, Nakane PK, Mori S. Sugawara I, et al. Among authors: gottesman mm. Jpn J Cancer Res. 1990 Sep;81(9):949-55. doi: 10.1111/j.1349-7006.1990.tb02672.x. Jpn J Cancer Res. 1990. PMID: 1977730 Free PMC article.

3

P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance.

Kioka N, Tsubota J, Kakehi Y, Komano T, Gottesman MM, Pastan I, Ueda K. Kioka N, et al. Among authors: gottesman mm. Biochem Biophys Res Commun. 1989 Jul 14;162(1):224-31. doi: 10.1016/0006-291x(89)91985-2. Biochem Biophys Res Commun. 1989. PMID: 2568832

4

MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants.

Kanamaru H, Kakehi Y, Yoshida O, Nakanishi S, Pastan I, Gottesman MM. Kanamaru H, et al. Among authors: gottesman mm. J Natl Cancer Inst. 1989 Jun 7;81(11):844-9. doi: 10.1093/jnci/81.11.844. J Natl Cancer Inst. 1989. PMID: 2724349

5

Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance.

Kakehi Y, Kanamaru H, Yoshida O, Ohkubo H, Nakanishi S, Gottesman MM, Pastan I. Kakehi Y, et al. Among authors: gottesman mm. J Urol. 1988 Apr;139(4):862-5. doi: 10.1016/s0022-5347(17)42663-2. J Urol. 1988. PMID: 3352061

6

In vivo models of P-glycoprotein-mediated multidrug resistance.

Gottesman MM, Mickisch GH, Pastan I. Gottesman MM, et al. Cancer Treat Res. 1994;73:107-28. doi: 10.1007/978-1-4615-2632-2_6. Cancer Treat Res. 1994. PMID: 7710902 Review. No abstract available.

7

Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.

Cardarelli CO, Aksentijevich I, Pastan I, Gottesman MM. Cardarelli CO, et al. Among authors: gottesman mm. Cancer Res. 1995 Mar 1;55(5):1086-91. Cancer Res. 1995. PMID: 7866993

8

Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants.

Nguyen KT, Liu B, Ueda K, Gottesman MM, Pastan I, Chin KV. Nguyen KT, et al. Among authors: gottesman mm. Oncol Res. 1994;6(2):71-7. Oncol Res. 1994. PMID: 7949467

9

P-glycoproteins: mediators of multidrug resistance.

Germann UA, Pastan I, Gottesman MM. Germann UA, et al. Among authors: gottesman mm. Semin Cell Biol. 1993 Feb;4(1):63-76. doi: 10.1006/scel.1993.1008. Semin Cell Biol. 1993. PMID: 8095827 Review.

10

Biochemistry of multidrug resistance mediated by the multidrug transporter.

Gottesman MM, Pastan I. Gottesman MM, et al. Annu Rev Biochem. 1993;62:385-427. doi: 10.1146/annurev.bi.62.070193.002125. Annu Rev Biochem. 1993. PMID: 8102521 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

569 results

Search Page

Filters